These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19684159)

  • 21. Purification and characterization of two mannan-binding lectins from mouse serum.
    Hansen S; Thiel S; Willis A; Holmskov U; Jensenius JC
    J Immunol; 2000 Mar; 164(5):2610-8. PubMed ID: 10679100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of active or passive immunization on the response of the ligated rabbit intestine to Shigella flexneri infection.
    Ogawa H; Nakamura A
    Jpn J Med Sci Biol; 1969 Dec; 22(6):351-62. PubMed ID: 5309565
    [No Abstract]   [Full Text] [Related]  

  • 23. IFNγ inhibits the cytosolic replication of Shigella flexneri via the cytoplasmic RNA sensor RIG-I.
    Jehl SP; Nogueira CV; Zhang X; Starnbach MN
    PLoS Pathog; 2012; 8(8):e1002809. PubMed ID: 22912573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prokaryotic expression of Balb/C mouse MBL-A carbohydrate recognition domain].
    Zuo DM; Zhang LY; Lu X; Chen ZL
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Feb; 29(2):267-70. PubMed ID: 19246296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virulent Shigella flexneri subverts the host innate immune response through manipulation of antimicrobial peptide gene expression.
    Sperandio B; Regnault B; Guo J; Zhang Z; Stanley SL; Sansonetti PJ; Pédron T
    J Exp Med; 2008 May; 205(5):1121-32. PubMed ID: 18426984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity and protective efficacy offered by a ribosomal-based vaccine from Shigella flexneri 2a.
    Shim DH; Chang SY; Park SM; Jang H; Carbis R; Czerkinsky C; Uematsu S; Akira S; Kweon MN
    Vaccine; 2007 Jun; 25(25):4828-36. PubMed ID: 17507120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mannose binding lectin plays a crucial role in innate immunity against yeast by enhanced complement activation and enhanced uptake of polymorphonuclear cells.
    van Asbeck EC; Hoepelman AI; Scharringa J; Herpers BL; Verhoef J
    BMC Microbiol; 2008 Dec; 8():229. PubMed ID: 19094203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei.
    Formal SB; Oaks EV; Olsen RE; Wingfield-Eggleston M; Snoy PJ; Cogan JP
    J Infect Dis; 1991 Sep; 164(3):533-7. PubMed ID: 1869840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-administration of rIpaB domain of Shigella with rGroEL of S. Typhi enhances the immune responses and protective efficacy against Shigella infection.
    Chitradevi ST; Kaur G; Uppalapati S; Yadav A; Singh D; Bansal A
    Cell Mol Immunol; 2015 Nov; 12(6):757-67. PubMed ID: 25640657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a.
    Dharmasena MN; Osorio M; Takeda K; Stibitz S; Kopecko DJ
    Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29046309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and characterization of recombinant chicken mannose binding lectin.
    Zhang W; van Eijk M; Guo H; van Dijk A; Bleijerveld OB; Verheije MH; Wang G; Haagsman HP; Veldhuizen EJ
    Immunobiology; 2017 Mar; 222(3):518-528. PubMed ID: 27817988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AroD deletion attenuates Shigella flexneri strain 2457T and makes it a safe and efficacious oral vaccine in monkeys.
    Kärnell A; Cam PD; Verma N; Lindberg AA
    Vaccine; 1993; 11(8):830-6. PubMed ID: 8356844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunity in shigellosis. I. Response of man to attenuated strains of Shigella.
    DuPont HL; Hornick RB; Snyder MJ; Libonati JP; Formal SB; Gangarosa EJ
    J Infect Dis; 1972 Jan; 125(1):5-11. PubMed ID: 4550417
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of a fluid-phase PRR in fighting an intracellular pathogen: PTX3 in Shigella infection.
    Ciancarella V; Lembo-Fazio L; Paciello I; Bruno AK; Jaillon S; Berardi S; Barbagallo M; Meron-Sudai S; Cohen D; Molinaro A; Rossi G; Garlanda C; Bernardini ML
    PLoS Pathog; 2018 Dec; 14(12):e1007469. PubMed ID: 30532257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Divalent metal ions binding properties of goat serum mannose binding lectin.
    Patel PK; Hindala M; Kohli B; Hajela K
    Int J Biol Macromol; 2015 Sep; 80():324-7. PubMed ID: 26126945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mannan-Binding Lectin Suppresses Peptidoglycan-Induced TLR2 Activation and Inflammatory Responses.
    Wang F; Li Y; Yang C; Mu Y; Wang Y; Zhang W; Yang Y; Chen C; Song S; Shen Z; Wang W; Li J; Zhai J; Guo K; Sun R; Yu L; Wang M
    Mediators Inflamm; 2019; 2019():1349784. PubMed ID: 30728747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New animal model of shigellosis in the Guinea pig: its usefulness for protective efficacy studies.
    Shim DH; Suzuki T; Chang SY; Park SM; Sansonetti PJ; Sasakawa C; Kweon MN
    J Immunol; 2007 Feb; 178(4):2476-82. PubMed ID: 17277155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccination with Shigella flexneri 2a conjugate induces type 2a and cross-reactive type 6 antibodies in humans but not in mice.
    Farzam N; Ramon-Saraf R; Banet-Levi Y; Lerner-Geva L; Ashkenazi S; Kubler-Kielb J; Vinogradov E; Robbins JB; Schneerson R
    Vaccine; 2017 Sep; 35(37):4990-4996. PubMed ID: 28797729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blockade of CD14 aggravates experimental shigellosis.
    Wennerås C; Ave P; Huerre M; Arondel J; Ulevitch R; Mathison J; Sansonetti P
    J Endotoxin Res; 2001; 7(6):442-6. PubMed ID: 11753214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Modern concepts of immunity in bacterial dysentery (a review)].
    Pokrovskiĭ VI; Litinskiĭ IuI; Godovannyĭ BA
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Sep; (9):15-21. PubMed ID: 4613079
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.